ViiV Healthcare reports positive data for two phase 3 HIV trials of cabotegravir, rilpivirine regimen

Image: ViiV Healthcare reports positive data for two phase 3 HIV trials of cabotegravir, rilpivirine regimen. Photo: courtesy of ponsulak/FreeDigitalPhotos.net.